A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy
- PMID: 29396306
- PMCID: PMC5897918
- DOI: 10.1016/j.ebiom.2017.12.029
A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy
Abstract
Background: Rapid Point-Of-Care Tests for Chlamydia trachomatis (CT) may reduce onward transmission and reproductive sexual health (RSH) sequelae by reducing turnaround times between diagnosis and treatment. The io® single module system (Atlas Genetics Ltd.) runs clinical samples through a nucleic acid amplification test (NAAT)-based CT cartridge, delivering results in 30min.
Methods: Prospective diagnostic accuracy study of the io® CT-assay in four UK Genito-Urinary Medicine (GUM)/RSH clinics on additional-to-routine self-collected vulvovaginal swabs. Samples were tested "fresh" within 10days of collection, or "frozen" at -80°C for later testing. Participant characteristics were collected to assess risk factors associated with CT infection.
Results: CT prevalence was 7.2% (51/709) overall. Sensitivity, specificity, positive and negative predictive values of the io® CT assay were, respectively, 96.1% (95% Confidence Interval (CI): 86.5-99.5), 97.7% (95%CI: 96.3-98.7), 76.6% (95%CI: 64.3-86.2) and 99.7% (95%CI: 98.9-100). The only risk factor associated with CT infection was being a sexual contact of an individual with CT.
Conclusions: The io® CT-assay is a 30-min, fully automated, high-performing NAAT currently CE-marked for CT diagnosis in women, making it a highly promising diagnostic to enable specific treatment, initiation of partner notification and appropriately intensive health promotion at the point of care.
Keywords: Chlamydia trachomatis; Diagnostic accuracy; Performance evaluation; Point-of-care; Rapid test; Risk factor.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.
Figures

Similar articles
-
Systematic reviews of point-of-care tests for the diagnosis of urogenital Chlamydia trachomatis infections.Sex Transm Infect. 2017 Dec;93(S4):S22-S30. doi: 10.1136/sextrans-2016-053067. Sex Transm Infect. 2017. PMID: 29223960 Review.
-
Point-of-care test for detection of urogenital chlamydia in women shows low sensitivity. A performance evaluation study in two clinics in Suriname.PLoS One. 2012;7(2):e32122. doi: 10.1371/journal.pone.0032122. Epub 2012 Feb 29. PLoS One. 2012. PMID: 22393383 Free PMC article.
-
Diagnostic accuracy of a prototype rapid chlamydia and gonorrhoea recombinase polymerase amplification assay: a multicentre cross-sectional preclinical evaluation.Clin Microbiol Infect. 2019 Mar;25(3):380.e1-380.e7. doi: 10.1016/j.cmi.2018.06.003. Epub 2018 Jun 12. Clin Microbiol Infect. 2019. PMID: 29906594 Free PMC article.
-
Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse.Pediatr Infect Dis J. 2009 Jul;28(7):608-13. doi: 10.1097/INF.0b013e31819b592e. Pediatr Infect Dis J. 2009. PMID: 19451856
-
Rapid point of care test for detecting urogenital Chlamydia trachomatis infection in nonpregnant women and men at reproductive age.Cochrane Database Syst Rev. 2020 Jan 29;1(1):CD011708. doi: 10.1002/14651858.CD011708.pub2. Cochrane Database Syst Rev. 2020. PMID: 31995238 Free PMC article.
Cited by
-
Performance of the Atlas Genetics Rapid Test for Chlamydia trachomatis and Women's Attitudes Toward Point-Of-Care Testing.Sex Transm Dis. 2018 Nov;45(11):723-727. doi: 10.1097/OLQ.0000000000000865. Sex Transm Dis. 2018. PMID: 29771869 Free PMC article.
-
Multiplex Detection of Infectious Diseases on Microfluidic Platforms.Biosensors (Basel). 2023 Mar 21;13(3):410. doi: 10.3390/bios13030410. Biosensors (Basel). 2023. PMID: 36979622 Free PMC article. Review.
-
Performance of point-of-care tests for the detection of chlamydia trachomatis infections: A systematic review and meta-analysis.EClinicalMedicine. 2021 Jun 18;37:100961. doi: 10.1016/j.eclinm.2021.100961. eCollection 2021 Jul. EClinicalMedicine. 2021. PMID: 34195578 Free PMC article.
-
DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas.Parasit Vectors. 2020 Oct 27;13(1):533. doi: 10.1186/s13071-020-04414-6. Parasit Vectors. 2020. PMID: 33109267 Free PMC article.
-
Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.Clin Infect Dis. 2022 Apr 13;74(Suppl_2):S112-S126. doi: 10.1093/cid/ciac126. Clin Infect Dis. 2022. PMID: 35416965 Free PMC article.
References
-
- Abbott Abbott RealTime CT/NG. [Online] 2010. https://www.molecular.abbott/sal/en-us/staticAssets/ctng-8l07-91-us-fina... Package Insert. Available from.
-
- Alonzo T.A., Pepe M.S. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat. Med. [Online] 1999;18(22):2987–3003. http://www.ncbi.nlm.nih.gov/pubmed/10544302 Available from. - PubMed
-
- Atkinson L.M., Vijeratnam D., Mani R., Patel R. ‘The waiting game’: are current chlamydia and gonorrhoea near-patient/point-of-care tests acceptable to service users and will they impact on treatment? Int. J. of STD & AIDS. [Online] 2016;27(8):650–655. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical